To cap off a successful trip to Japan, Incubate executive director John Stanford sat down with a panel of biotech investors, founders, and industry leaders for an episode of the Making Medicine podcast . John was joined by Shaan Gandhi of Pfizer, Patrick Jordan of NovaQuest Capital Management, Heather Berger of Forge Life Science Partners, and Johannes Fruehauf of BioLabs Global Inc to discuss Japan's emerging biotech hub. Japan's life sciences sector is growing quickly, driv

Incubate executive director John Stanford was featured in a BioSpace  article by news editor Dan Samorodnitsky on how the ongoing federal government shutdown is affecting the Food and Drug Administration and the broader biopharmaceutical ecosystem. As the shutdown stretches on, Stanford warned that uncertainty and funding lapses are beginning to slow biotech activity and signal risk to the United States' standing as the global center for innovation. He noted that the prolonge

Incubate executive director John Stanford recently sat down with Joshua Kresh for an episode of the Making Medicine podcast  to talk about all things intellectual property (IP). Kresh leads the Institute for Progress & Innovation (IPPI) , where he focuses on strengthening the policies that support scientific progress. IP underpins everything from movies and music to, most importantly, the medicines we rely on. Drug development is slow, risky, and enormously expensive, often t

WASHINGTON ( Sep 30 ) -- Today, the Trump administration announced its first agreement with a manufacturer to bring most-favored-nation...

Incubate executive director John Stanford was featured in an Investor's Business Daily  article by reporter Allison Gatlin on the Trump administration's effort to implement a "Most Favored Nation" (MFN) policy for prescription drugs -- a proposal that would tie U.S. prices to those paid in other wealthy nations. As policymakers push to curb drug costs, Stanford cautioned that policies like MFN risk undermining  the investment ecosystem that fuels the development of new medici